FDA approves #lecenemab via accelerated mechanism (same as #aducanumab):

https://www.statnews.com/2023/01/06/fda-approves-alzheimers-drug-leqembi-eisai/

CMS will still need to decide about Medicare coverage.

Eisai expected to seek full FDA approval based on additional cognitive outcomes data.

#dementia #alzheimers